<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03729934</url>
  </required_header>
  <id_info>
    <org_study_id>KBS2018</org_study_id>
    <nct_id>NCT03729934</nct_id>
  </id_info>
  <brief_title>Ketones Supplementation and Postprandial Lipemia</brief_title>
  <official_title>Effects of Ketones Supplementation on Postprandial Lipemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study determines whether different forms of ketones supplemented prior to a meal lower&#xD;
      the triglyceride (fat) content in the blood of overweight and obese individuals. Through a&#xD;
      randomized crossover design, participants (n=15) will participate in each of the following&#xD;
      three experimental groups (no treatment control, ketone ester, ketone salt), with a 5-14 day&#xD;
      washout period between each experimental visit.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous studies conducted by the investigative team in rodents show that male mice fed a&#xD;
      diet containing 30% ketone ester (by kcals) results in greater fecal content and energy loss.&#xD;
      While the investigators are unsure of the exact macronutrient content of the energy loss, the&#xD;
      hypothesis is that the energy excretion is attributed to lower fat absorption. In the context&#xD;
      of this study, it's hypothesized that ketone salts and ketone esters (both available&#xD;
      commercially and used for a variety of health-related claims) will reduce the absorption of&#xD;
      dietary fats leading to lower circulating triglyceride concentrations if consumed prior to a&#xD;
      high-fat mixed meal. If the hypothesis is correct, ketones supplementation could become a&#xD;
      valuable strategy to reduce the rise in circulating triglycerides often present in obesity.&#xD;
      Triglyceride concentrations in the blood following a meal have been linked to development of&#xD;
      cardiovascular disease.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Dissertation for student changed.&#xD;
  </why_stopped>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Actual">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline plasma glucagon-like peptide 1 at 240 minutes</measure>
    <time_frame>0, 30, 60, 120, 180, and 240 minutes post-supplement consumption</time_frame>
    <description>Plasma levels of glucagon-like peptide 1 in pg/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline serum triglycerides at 240 minutes</measure>
    <time_frame>0, 30, 60, 120, 180, and 240 minutes post-supplement consumption</time_frame>
    <description>Serum levels of triglycerides in mg/DL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline serum glucose at 240 minutes</measure>
    <time_frame>0, 30, 60, 120, 180, and 240 minutes post-supplement consumption</time_frame>
    <description>Serum levels of glucose in mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline serum Insulin at 240 minutes</measure>
    <time_frame>0, 30, 60, 120, 180, and 240 minutes post-supplement consumption</time_frame>
    <description>Serum levels of insulin in pmol/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline serum B-hydroxybutyrate at 240 minutes</measure>
    <time_frame>0, 30, 60, 120, 180, and 240 minutes post-supplement consumption</time_frame>
    <description>Serum levels of B-hydroxybutyrate in mmol/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline plasma ghrelin at 240 minutes</measure>
    <time_frame>0, 30, 60, 120, 180, and 240 minutes post-supplement consumption</time_frame>
    <description>Plasma levels of ghrelin in pg/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline plasma leptin at 240 minutes</measure>
    <time_frame>0, 30, 60, 120, 180, and 240 minutes post-supplement consumption</time_frame>
    <description>Plasma levels of leptin in ng/mL</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Obesity</condition>
  <condition>Overweight and Obesity</condition>
  <condition>Overweight</condition>
  <condition>Triglycerides High</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This arm receives no treatment control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketone Ester</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm receives 25 g ketone ester.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketone Salt</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm receives 25 g ketone salt.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ketone Ester</intervention_name>
    <description>This arm receives 25 g ketone ester.</description>
    <arm_group_label>Ketone Ester</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ketone Salt</intervention_name>
    <description>This arm receives 25 g ketone salt.</description>
    <arm_group_label>Ketone Salt</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Overweight or obese men as defined by a BMI of greater than or equal to 25 kg/m2, but&#xD;
             less than 35 kg/m2&#xD;
&#xD;
          -  Between the ages of 25 and 45 years&#xD;
&#xD;
          -  Fasting triglyceride levels less than 250 mg/dL&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participates in regular physical activity (â‰¥3 days/week at 30 minutes or more per day)&#xD;
&#xD;
          -  Diagnosed cardiovascular disease or metabolic disease (type 1 or type 2 diabetes)&#xD;
&#xD;
          -  Currently following a low carbohydrate (&lt;100 g/day) diet&#xD;
&#xD;
          -  Lost greater than or equal to 5% body weight over the last 2 months&#xD;
&#xD;
          -  Alcohol/smoking/antibiotics&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 23, 2018</study_first_submitted>
  <study_first_submitted_qc>November 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2018</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Eric P. Plaisance</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

